PHD指蛋白10通过调节胃癌中CD44转录来促进细胞增殖
Zhiyuan Fan1,2, Xiao Jiang3, Wenjing Yan1
1Department of General Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Heliyon
|April 11, 2024
概括
PHD指蛋白10 (PHF10) 促进胃癌 (GC) 的进展和转移. 针对PHF10及其下游CD44为GC患者提供了潜在的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- PHD指蛋白10 (PHF10) 与胃癌 (GC) 瘤发生有关.
- 在GC中PHF10的确切临床意义和分子机制在很大程度上仍未确定.
研究的目的:
- 研究PHF10在胃癌中的临床意义和分子机制.
- 探索在GC中准PHF10的诊断价值和治疗潜力.
主要方法:
- 对GC患者数据集和瘤组织的分析.
- 建立具有PHF10过度表达和淘汰的GC细胞系.
- CCK8测定,瘤异种移植实验,以及对CD44 mRNA表达的分析.
- 研究与SWI/SNF复杂子单元 (BRG,BAF155,SNF5) 的关联.
主要成果:
- PHF10在GC中显示出诊断价值 (AUC = 0.71 ± 0.069).
- 过度表达PHF10促进了GC细胞的增殖,而抑制抑制了它在体外和体内.
- PHF10通过转录上调调节CD44mRNA表达,可能涉及SWI/SNF复合体.
结论:
- PHF10在调节GC细胞增殖和转移方面发挥着至关重要的作用.
- PHF10针对CD44,表明它是GC的潜在治疗点.
- 针对PHF10-CD44相互作用可能为胃癌提供一种新的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


